]> 2026-04-12T04:14:19-07:00 Tamoxifen 0 en Tamoxifen has been approved by FDA for breast cancer and while it is under investigation for glioblastoma, its high dosage use can lead to certain side effects. These include blood clots, potential risk of uterine cancer in women and impotence in men. Further, weight gain is also observed as a common side effect. Therefore, it is rated 3.5 in toxicity due to these common side effects and the potential serious health risks associated with its usage. 2025-01-18T08:16:59Z 2460693.8451273 Tamoxifen Has treatment name 102 en Has treatment name